Therefore, the hyper-methylation of SOCS3 in the gene promoter and its nearby region silences the inhibitory effect on leptin and insulin of SOCS3, whereas hyper-methylation in the gene body facilitates it to inhibit the activity of insulin and leptin, resulting in a high risk of obesity. This evidence concerns the gene LEP and obesity disorder.